Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma

Lancet

Volumn 352, Issue 9134, 1998, Pages 1109-1113

  Kon, Onn M ^a   Sihra, Bhupinder S ^b   Compton, Christopher H ^c   Leonard, Thomas B ^d   Kay, A Barry ^b   Barnes, Neil C ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d London Chest Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHIMERIC ANTIBODY; KELIXIMAB; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ECZEMA; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032480574     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)12261-9     Document Type: Article

References (24)

1. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-13.
2. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-42.
3. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-39.
4. Till S, Li B, Durham S, et al. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 1995; 25: 2727-31.
5. Walker C, Virchow JC Jr, Bruijnzeel PL, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146: 1829-35.
6. Robinson DS, Bentley AM, Hartnell A, Kay AB, Durham SR. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 1993; 48: 26-32.
7. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma: relationship to disease severity and atopic status. Am Rev Respir Dis 1990; 141: 970-77.
8. The British Guidelines on Asthma Management. Thorax 1997; 52: S1-21.
9. International Consensus Report on Diagnosis and Treatment of Asthma. Clin Exp Allergy 1992; 22 (suppl 1): 1-72.
10. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomised, doubleblind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990; 336: 137-40.
11. Bernstein IL, Bernstein DI, Dubb JW, Faiferman I, Wallin B. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma: Auranofin Multicenter Drug Trial. J Allergy Clin Immunol 1996; 98: 317-24.
12. Lock SH, Kay AB, Barnes NC. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med 1996; 153: 509-14.
13. Reinke P, Volk HD, Miller H, et al. Anti-CD4 therapy of acute rejection in long-term renal allograft recipients. Lancet 1991; 338: 702-03.
14. Herzog C, Walker C, Pichler W, et al. Monoclonal anti-CD4 in arthritis. Lancet 1987; ii: 1461-62.
15. Choy EH, Kingsley GH, Panayi GS. Treatment with anti-CD4 monoclonal antibody and acute interstitial nephritis. Arthritis Rheum 1993; 36: 723-24.
16. Wofsey D, Carteron NL. CD4 antibody therapy in systemic lupus erythematosus. Semin Immunol 1990; 2: 419-25.
17. Prinz J, Braun-Falco O, Meurer M, et al. Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet 1991; 338: 320-21.
18. Newman R, Alberts J, Anderson D, et al. "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology N Y 1992; 10: 1455-60.
19. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
20. Jeyarajah DR, Thistlethwaite JRJ. General aspects of cytokine-release syndrome: timing and incidence of symptoms. Transplant Proc 1993; 25: 16-20.
21. Stewart SJ, Fujimoto J, Levy R. Human T lymphocytes and monocytes bear the same Leu-3 (T4) antigen. J Immunol 1986; 136: 3773-78.
22. Rosenzwajg M, Canque B, Gluckman JC. Human dentritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 1996; 87: 535-44.
23. Lucey DR, Dorsky DI, Nicholson Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med 1989; 169: 327-32.
24. Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WL. Treatment of refractory rheumatoid arthtritis with a chimeric anti-CD4 monoclonal antibody: long-term followup of CD4+ T cell counts. Arthritis Rheum 1994; 37: 834-38.